Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Eclinicalmedicine|May 13, 2024
Comparison of safety and efficacy between Nirmatrelvir-ritonavir and molnupiravir in the treatment of COVID-19 infection in patients with advanced kidney disease: a retrospective observational studyWing Ming Chu, Eric Yuk Fai Wan, Zoey Cho Ting Wong, et al.
Vascular Pharmacology|September 13, 2015
Activation of endothelial IKCa channels underlies NO-dependent myoendothelial feedbackPaul M Kerr, Ran Wei, Raymond Tam, et al.
The Lancet. Infectious Diseases|July 18, 2024
Comparative effectiveness of combination therapy with nirmatrelvir-ritonavir and remdesivir versus monotherapy with remdesivir or nirmatrelvir-ritonavir in patients hospitalised with COVID-19: a target trial emulation studyMing Hong Choi, Eric Yuk Fai Wan, Ian Chi Kei Wong, et al.
The Clinical Respiratory Journal|March 27, 2025
Implication of Admission Eosinophil Count and Prognosis of Coronavirus Disease 2019 (COVID-19) in Elderly Patients With COPD: A Territory-Wide Cohort StudyWang Chun Kwok, Yat Fung Shea, James Chung Man Ho, et al.
Nephrology (Carlton, Vic.)|September 20, 2020
Case of "relapsing" COVID-19 in a kidney transplant recipientBecky Mingyao Ma, Ivan Fan Ngai Hung, Gary Chi Wang Chan, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 5, 2025
Comparative effectiveness of combination therapy with nirmatrelvir-ritonavir and molnupiravir versus monotherapy with molnupiravir or nirmatrelvir-ritonavir in hospitalized COVID-19 patients: A target trial emulation studyEric Yuk Fai Wan, Ming Hong Choi, Boyuan Wang, et al.
Canadian Journal of Physiology and Pharmacology|May 1, 2013
Triton X-100 inhibits L-type voltage-operated calcium channelsDeepak Narang, Paul M Kerr, Jason Baserman, et al.
The Clinical Respiratory Journal|February 11, 2022
Asthma, from mild to severe, is an independent prognostic factor for mild to severe Coronavirus disease 2019 (COVID-19)Wang Chun Kwok, Anthony Raymond Tam, James Chung Man Ho, et al.
Heliyon|August 21, 2024
The impact of vaccine type and booster dose on the magnitude and breadth of SARS-CoV-2-specific systemic and mucosal antibodies among COVID-19 vaccine recipientsHoi-Wah Tsoi, Miko Ka-Wai Ng, Jian-Piao Cai, et al.
Frontiers in Immunology|October 28, 2022
Comparing the B and T cell-mediated immune responses in patients with type 2 diabetes receiving mRNA or inactivated COVID-19 vaccinesChi-Ho Lee, Victor Gray, Jia Ming Nickolas Teo, et al.
Pageof 7